We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$59.8B
AUM Growth
+$5.07B
Cap. Flow
+$518M
Cap. Flow %
0.87%
Top 10 Hldgs %
18.08%
Holding
2,992
New
38
Increased
2,358
Reduced
537
Closed
43

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$68M
2
TFC icon
Truist Financial
TFC
+$55.9M
3
NOW icon
ServiceNow
NOW
+$33.3M
4
UBER icon
Uber
UBER
+$21.4M
5
LVS icon
Las Vegas Sands
LVS
+$15.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$119M
2
STI
SunTrust Banks, Inc.
STI
+$55.9M
3
AAPL icon
Apple
AAPL
+$48.3M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$22M
5
VIAB
Viacom Inc. Class B
VIAB
+$16.4M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Financials 15.53%
3 Healthcare 13.38%
4 Consumer Discretionary 10.07%
5 Industrials 9.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KVHI icon
2626
KVH Industries
KVHI
$179M
$283K ﹤0.01%
25,432
+10
+0% +$106
STRS icon
2627
Stratus Properties
STRS
$157M
$283K ﹤0.01%
9,149
-15
-0.2% -$430
BFIN
2628
DELISTED
BankFinancial
BFIN
$279K ﹤0.01%
21,325
+209
+1% +$2.72K
BPRN icon
2629
Princeton Bancorp
BPRN
$289M
$279K ﹤0.01%
8,867
+55
+0.6% +$1.62K
SFE
2630
DELISTED
Safeguard Scientifics, Inc.
SFE
$279K ﹤0.01%
25,434
+100
+0.4% +$1.14K
UNTY icon
2631
Unity Bancorp
UNTY
$594M
$278K ﹤0.01%
12,303
-38
-0.3% -$841
FRBA icon
2632
First Bank
FRBA
$471M
$277K ﹤0.01%
25,086
-69
-0.3% -$747
RVSB icon
2633
Riverview Bancorp
RVSB
$109M
$277K ﹤0.01%
33,701
+310
+0.9% +$2.32K
MTEM
2634
DELISTED
Molecular Templates, Inc.
MTEM
$277K ﹤0.01%
1,321
+11
+0.8% +$1.58K
FNHC
2635
DELISTED
FedNat Holding Company Common Stock
FNHC
$277K ﹤0.01%
16,659
-16
-0.1% -$239
CBMG
2636
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$275K ﹤0.01%
16,949
+490
+3% +$8.17K
RLGT icon
2637
Radiant Logistics
RLGT
$393M
$274K ﹤0.01%
49,255
+208
+0.4% +$1.13K
VRCA icon
2638
Verrica Pharmaceuticals
VRCA
$90.2M
$274K ﹤0.01%
1,723
+31
+2% +$4.57K
SBT
2639
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$273K ﹤0.01%
33,696
+5,430
+19% +$50.5K
TCFC
2640
DELISTED
The Community Financial Corporation Common Stock
TCFC
$273K ﹤0.01%
7,682
-31
-0.4% -$1.05K
SYRS
2641
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$272K ﹤0.01%
3,939
+46
+1% +$2.79K
OPTN
2642
DELISTED
OptiNose
OPTN
$268K ﹤0.01%
1,936
+18
+0.9% +$2.33K
WLFC icon
2643
Willis Lease Finance
WLFC
$1.74B
$268K ﹤0.01%
13,647
+93
+0.7% +$1.81K
AXTI icon
2644
AXT Inc
AXTI
$4.27B
$266K ﹤0.01%
61,261
-259
-0.4% -$832
EML icon
2645
Eastern Company
EML
$149M
$266K ﹤0.01%
8,710
– –
EVER icon
2646
EverQuote
EVER
$852M
$266K ﹤0.01%
+7,740
New +$216K
MRSN
2647
DELISTED
Mersana Therapeutics
MRSN
$266K ﹤0.01%
1,854
+98
+6% +$7.17K
SRRK icon
2648
Scholar Rock
SRRK
$5.49B
$266K ﹤0.01%
20,201
+648
+3% +$6.22K
SCWX
2649
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$266K ﹤0.01%
15,951
-262
-2% -$3.38K
HCAT icon
2650
Health Catalyst
HCAT
$163M
$264K ﹤0.01%
7,607
+261
+4% +$8.64K
104 105
106
107 108

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2019 Portfolio in Review

As of Q4 2019, RhumbLine Advisers held 2,992 positions worth $59.8B, up 9.3% from $54.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 2.7%. RhumbLine Advisers opened 38 new positions and exited 43, leaving the 2,992-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2019 buy was Envista: 126,664 shares worth $3.75M.
  • RhumbLine Advisers added most to Bristol-Myers Squibb in Q4 2019, an estimated $68M increase.
  • RhumbLine Advisers's biggest Q4 2019 reduction was Apple, cutting an estimated $48.3M.
  • RhumbLine Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $119M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $59.8B portfolio in Q4 2019.
  • RhumbLine Advisers opened 38 new positions and closed 43 in Q4 2019.
  • RhumbLine Advisers's portfolio value rose 9.3% quarter-over-quarter to $59.8B.

Based on RhumbLine Advisers's 13F filing for Q4 2019, filed 5 Feb 2020.